awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33628778-8A4F64A7-E0BF-49B6-A19D-6956486D1C25
Q33628778-8A4F64A7-E0BF-49B6-A19D-6956486D1C25
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33628778-8A4F64A7-E0BF-49B6-A19D-6956486D1C25
Phase II trial of pemetrexed plus bevacizumab for second-line therapy of patients with advanced non-small-cell lung cancer: NCCTG and SWOG study N0426.
P2860
Q33628778-8A4F64A7-E0BF-49B6-A19D-6956486D1C25
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33628778-8A4F64A7-E0BF-49B6-A19D-6956486D1C25
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0575939eba712e7896a547847332ce2e524e905e
P2860
The mechanism of transport of the multitargeted antifolate (MTA) and its cross-resistance pattern in cells with markedly impaired transport of methotrexate.